Yuen Wo Tsang
Technik-/Wissenschafts-/F&E-Leiter bei WAI YUEN TONG MEDICINE HOLDINGS LIMITED
Aktive Positionen von Yuen Wo Tsang
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| WAI YUEN TONG MEDICINE HOLDINGS LIMITED | Technik-/Wissenschafts-/F&E-Leiter | 01.09.2018 | - |
Luxembourg Institute of Health
 Luxembourg Institute of Health Miscellaneous Commercial ServicesCommercial Services Luxembourg Institute of Health (LIH) is an interdisciplinary research organization that focuses on identifying environmental, lifestyle, and behavioral factors affecting health. The private company is based in Strassen, Luxembourg. LIH uses its expertise in digital epidemiology, human biomonitoring, sport medicine, nutrition, and molecular biology to support the implementation and evaluation of new e-health technologies in the context of disease prevention and improving population health. Cancer is a priority disease for LIH, and Precision Oncology is at the heart of their efforts. The CEO of the Luxembourger company is Ulf Nehrbass. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Karriereverlauf von Yuen Wo Tsang
Ausbildung von Yuen Wo Tsang
| University of Aston | Undergraduate Degree |
| The University of Sydney | Graduate Degree |
Statistik
International
| Hong Kong | 2 |
| Vereinigtes Königreich | 2 |
| Australien | 2 |
Operativ
| Chief Tech/Sci/R&D Officer | 2 |
| Undergraduate Degree | 1 |
| Graduate Degree | 1 |
Sektoral
| Consumer Services | 3 |
| Health Technology | 2 |
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| WAI YUEN TONG MEDICINE HOLDINGS LIMITED | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Luxembourg Institute of Health
Luxembourg Institute of Health Miscellaneous Commercial ServicesCommercial Services Luxembourg Institute of Health (LIH) is an interdisciplinary research organization that focuses on identifying environmental, lifestyle, and behavioral factors affecting health. The private company is based in Strassen, Luxembourg. LIH uses its expertise in digital epidemiology, human biomonitoring, sport medicine, nutrition, and molecular biology to support the implementation and evaluation of new e-health technologies in the context of disease prevention and improving population health. Cancer is a priority disease for LIH, and Precision Oncology is at the heart of their efforts. The CEO of the Luxembourger company is Ulf Nehrbass. | Commercial Services |
- Börse
- Insiders
- Yuen Wo Tsang
- Erfahrung
